L218CAR19
/ Henan Cancer Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 27, 2024
L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma
(clinicaltrials.gov)
- P1 | N=22 | Recruiting | Sponsor: Henan Cancer Hospital
New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 1
Of
1
Go to page
1